Cathedral Eye Clinic, 89-91 Academy Street, Belfast, BT1 2 LS, Northern Ireland, UK.
School of Mathematics and Physics, Queens University Belfast, Belfast, Northern Ireland, UK.
Int Ophthalmol. 2021 Dec;41(12):3985-3998. doi: 10.1007/s10792-021-01970-3. Epub 2021 Sep 21.
To assess the 1-month and 12-month postoperative visual performance and subjective outcomes following combined implantation of an extended depth of focus (EDOF) intraocular lens (IOL) and a trifocal IOL.
The study enrolled consecutive patients undergoing refractive lens extraction or cataract surgery with combined implantation of an EDOF IOL (dominant eye) and trifocal IOL. Uncorrected (UDVA) and best-corrected (CDVA) distance visual acuities, uncorrected intermediate (UIVA) and near (UNVA) visual acuities, and subjective questionnaires were evaluated 1 month and 12 months postoperatively.
The study enrolled 58 consecutive patients. Binocular UDVA, UIVA and UNVA were - 0.08 ± 0.07 logMAR, 0.15 ± 0.14 logMAR and 0.17 ± 0.11 logMAR at 1 month, compared to - 0.09 ± 0.06 logMAR (P = .323), 0.11 ± 0.10 logMAR (P = .030) and 0.13 ± 0.10 logMAR (P = 0.008) at 12 months. Satisfaction was high with 93.1% of patients fulfilled or more than fulfilled postoperatively, and 84.5% and 86.3% reported spectacle independence for near at the respective postoperative assessments. The mean daytime and nighttime quality of vision (QoV) scores were 9.12 ± 0.94 and 7.88 ± 1.74 at 1 month, compared to 9.24 ± 0.78 (P = .183) and 8.26 ± 1.38 (P = .043) at 12 months.
This IOL combination provides good unaided visual acuity at 1 and 12 months postoperatively, with high functional vision and postoperative satisfaction reported at 1 and 12 months. However, a significant improvement in overall nighttime QoV at the 12 months assessment was found.
评估联合植入扩展景深（EDOF）人工晶状体（IOL）和三焦点 IOL 后 1 个月和 12 个月的术后视觉表现和主观结果。
本研究纳入了连续接受屈光性晶状体切除术或白内障手术并联合植入 EDOF IOL（主导眼）和三焦点 IOL 的患者。术后 1 个月和 12 个月评估未矫正（UDVA）和最佳矫正（CDVA）远视力、未矫正中间（UIVA）和近（UNVA）视力以及主观问卷。
本研究共纳入 58 例连续患者。双眼 UDVA、UIVA 和 UNVA 在 1 个月时分别为-0.08±0.07logMAR、0.15±0.14logMAR 和 0.17±0.11logMAR，而在 12 个月时分别为-0.09±0.06logMAR（P=0.323）、0.11±0.10logMAR（P=0.030）和 0.13±0.10logMAR（P=0.008）。术后满意度高，93.1%的患者满足或超过术后期望，84.5%和 86.3%的患者分别在术后评估时报告近视力无需戴眼镜。日间和夜间的平均视觉质量（QoV）评分在 1 个月时分别为 9.12±0.94 和 7.88±1.74，而在 12 个月时分别为 9.24±0.78（P=0.183）和 8.26±1.38（P=0.043）。
这种 IOL 组合在术后 1 个月和 12 个月提供了良好的裸眼视力，术后 1 个月和 12 个月报告了高功能性视力和高术后满意度。然而，在 12 个月的评估中发现整体夜间 QoV 有显著改善。
